Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > Message to clairvoyant wyndewest.

<< Previous

Bullboard Posts

Next >>

Comment by aldo451on Aug 13, 2021 11:40pm

119 Views

Post# 33705583

RE:RE:Message to clairvoyant wyndewest.

Probably a lot more than you. Difference is I don't make up S H I T like you and your hideous buddies. You have been belching out your bogus baseless opinions without shame for the past year or more...out of money soon, will default any moment, imminent closure, only a few months of cash left, BLA approval will never happen.

You know what, they got Ryplazim approved, got the PRV, and what's more, sold it in two months for $105M USD. That's right, $105 fkn MILLION US dollars!!! Pretty DAMN good if you ask me! I was hoping for $50M to $75M but $105M...that is fkn awsome!

Please indulge us with you next fkd-up scenario!